Clinical Trial Update: Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

View source ↗

Summary

This Bristol-Myers Squibb sponsored study focuses on patient and physician preferences for treatments in resectable non-small cell lung cancer and is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-small Cell Lung Cancer (NSCLC) | Status: RECRUITING